| Name | CP-74416 methanesulfonate hydrate |
|---|---|
| Synonyms |
N-desmethyldanofloxacin methanesulfonate hydrate
Danofloxacin Impurity 1(N-Desmethyl Danofloxacin) 1-Cyclopropyl-7-(1S,4S)-2,5-diazabicyclo[2.2.1]ht-2-yl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecboxylic Acid 74416 methanesulfonate hydrate 1-Cyclopropyl-6-fluoro-1,4-dihydro-7-[(1β,4β)-3,6-diazabicyclo[2.2.1]htan-3-yl]-4-oxoquinoline-3-cboxylic acid 1-Cyclopropyl-6-fluoro-7-[(1α,4α)-2,5-diazabicyclo[2.2.1]htane-2-yl]-4-oxo-1,4-dihydroquinoline-3-cboxylic acid DESMETHYLDANOFLOXACIN 1-Cyclopropyl-7-(1S,4S)-2,5-diazabicyclo[2.2.1]ht-2-yl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecboxylic acid methanesulfonate hydrate 074416 methanesulfonate hydrate N-Desmethyl Danofloxacin 3-Quinolinecboxylic acid, 1-cyclopropyl-7-(1S,4S)-2,5-diazabicyclo[2.2.1]ht-2-yl-6-fluoro-1,4-dihydro-4-oxo |
| Density | 1.522g/cm3 |
|---|---|
| Boiling Point | 599ºC at 760mmHg |
| Molecular Formula | C18H18FN3O3 |
| Molecular Weight | 343.35200 |
| Flash Point | 316.1ºC |
| Exact Mass | 343.13300 |
| PSA | 74.57000 |
| LogP | 2.11800 |
| Vapour Pressure | 3.38E-15mmHg at 25°C |
| Index of Refraction | 1.687 |
|
~61%
108461-04-7 |
| Literature: Pfizer Inc. Patent: US4861779 A1, 1989 ; Title/Abstract Full Text Show Details Pfizer Inc. Patent: US4775668 A1, 1988 ; |
|
~63%
108461-04-7 |
| Literature: McGuirk; Jefson; Mann; Elliott; Chang; Cisek; Cornell; Gootz; Haskell; Hindahl; LaFleur; Rosenfeld; Shryock; Silvia; Weber Journal of Medicinal Chemistry, 1992 , vol. 35, # 4 p. 611 - 620 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |